Electronic informed consent (eConsent) solutions have been introduced in recent years, representing a major advancement in improving information delivery to study participants in clinical research. …

Adrenocortical carcinoma (ACC) is a rare cancer with an estimated incidence of 1 to 2 patients per million people annually. About 50%–70% of adrenal cancers …

Pediatric legislation was introduced based on the American Academy of Pediatrics (AAP) concerns that children did not participate sufficiently in therapeutic progress. But child healthcare …

Henry J. Riordan, Ph.D., Executive Vice President of Medical and Scientific Affairs and Global Lead for Neuroscience at Worldwide Clinical Trials, shares his views on …

A great number of willing patients, highly experienced researchers and EMA-compliant legislation make the CEE region an attractive research site destination. The data at large …

China has a large and vibrant ecosystem of patient advocacy groups and digital health networks that provides clinical trial sponsors with opportunities to engage and …

One area in the clinical trial process that has been identified for improvement is risk-based planning and management. Monitoring and managing risk has always been …

CDSIC is meant to enable you to collect, store and transfer clinical data in a way that makes them easily usable on a large scale …

Monoclonal antibodies (mAb) are among the most promising biologic drugs currently on the market for treatment of life-threatening diseases. The selectivity and specificity of these …

Pharmacovigilance will always be about protecting patients. The discipline is rapidly evolving into something greater than regulatory compliance; increasingly, pharmacovigilance has a central role to …